APPLICATION
ANDA203198
TYPE
ANDA
ORIGINAL APPROVAL
2014-06-12
LATEST ACTION
2022-02-15
ROUTE
INTRAVENOUS, SUBCUTANEOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
HEPARIN SODIUMPrescription
HEPARIN SODIUM 10,000 UNITS/ML · INJECTABLE · INJECTION
HEPARIN SODIUMPrescription
HEPARIN SODIUM 20,000 UNITS/ML · INJECTABLE · INJECTION
Approval history
2022-02-15Labeling · Supplement 13 · standardAP
2022-02-15Labeling · Supplement 12 · standardAP
2014-06-12UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.